{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:16:50Z","timestamp":1782458210271,"version":"3.54.5"},"reference-count":23,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"unspecified","delay-in-days":610,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.1080\/21645515.2019.1692557","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T16:11:42Z","timestamp":1576167102000},"page":"1392-1403","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Safety of the AS04-adjuvanted human papillomavirus (HPV)-16\/18 vaccine in adolescents aged 12\u201315 years: end-of-study results from a community-randomized study up to 6.5 years"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-4639","authenticated-orcid":false,"given":"Dan","family":"Bi","sequence":"first","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Apter","sequence":"additional","affiliation":[{"name":"Sexual Health Clinic, Family Federation of Finland, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Faculty of Social Sciences, University of Tampere, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Hokkanen","sequence":"additional","affiliation":[{"name":"Faculty of Social Sciences, University of Tampere, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Zima","sequence":"additional","affiliation":[{"name":"EMD Serono, Billerica, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4851-4396","authenticated-orcid":false,"given":"Silvia","family":"Damaso","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaria","family":"Soila","sequence":"additional","affiliation":[{"name":"GSK, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Dubin","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[{"name":"Faculty of Social Sciences, University of Tampere, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-0260","authenticated-orcid":false,"given":"Frank","family":"Struyf","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"cit0001","unstructured":"Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec (CIQ). Avis sur le calendrier de vaccination contre les virus du papillome humain (VPH). 2018. [accessed 2019 Sep 11]. https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2368_calendrier_vaccination_virus_papillome_humain.pdf."},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70287-X"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70286-8"},{"key":"cit0004","first-page":"CD009069","volume":"5","author":"Arbyn M","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015867"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c712"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1183847"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.019"},{"key":"cit0009","unstructured":"Kajantie M, Manderbacka K, McCallum A, Notkola I-L, Arffman M, Forssas E, Karvonen S, Kortteinen M, Leyland A, Keskim\u00e4ki I How to carry out register-based health services research in Finland? 2006. [accessed 2019 Sep 11]. http:\/\/www.stakes.fi\/verkkojulkaisut\/papers\/DP1-2006.pdf."},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.098"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.042"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1097\/00149831-200504000-00007"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1177\/1403494812456637"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2007.10.023"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.10.003"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.15167\/2421-4248\/jpmh2018.59.3.998"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.073"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.049"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X10361304"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60765-5"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00006-5"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.074"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1199308"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1692557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T20:47:16Z","timestamp":1629233236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1692557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,2]]}},"alternative-id":["10.1080\/21645515.2019.1692557"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1692557","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}